Ep. 107 - A Tale of Two Targets: LAG3, IL-2; Plus Alternatives to Cash Up
BioCentury This Week
00:00
Optivo and Dua for Two Combination With Flag?
After optava and catruda, were approved, everyone was throwing everything against the to see what was stick. So it's possible that what larn is saying is te field as sood o settled down. I don't know whether investors understand more biologye than they used to. But there's certainly this idea that larn has been talking about for some time.
Transcript
Play full episode
